Sibutramine clinical trials
Also written Meridia, ABT-991 and Reductil.
How each study uses sibutramine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 22 Nov 1997 · MERIDIA · NDA 020632 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
23 studies that test it; most in 2004 (5)
| Year | Studies |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 5 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 1 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 11 · Other 12
Abbott (5) · Yale University (2) · Mayo Clinic (2) · Eli Lilly and Company (2) · Promomed, LLC (1) · GlaxoSmithKline (1) · Merck Sharp & Dohme LLC (1) · AstraZeneca (1)
Often tested with
Tested in the same studies.
Orlistat (4) · Metformin (1) · Pramlintide (1) · Phentermine (1) · Diethylpropion (1) · LY-377604 (1)
Studies
Open first, then newest update. How each study uses sibutramine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 23
- Efficacy and Safety of Sibutramin-containing Drugs in Patient With Alimentary ObesityCompletedPhase 4Promomed, LLCNCT05821543Written as metformin+sibutramineHow we know
- Treatment of Binge Eating in Obese Patients in Primary CareCompletedPhase 4Yale UniversityNCT00537810Written as SibutramineHow we know
- Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped CareCompletedNot applicableYale UniversityNCT00829283Written as Sibutramine/OrlistatHow we know
- Studying the Effects of Sibutramine on Eating BehaviorTerminatedPhase 4New York State Psychiatric InstituteNCT01170364Written as SibutramineHow we know
- A Study to Characterise the Physiology of Weight Loss and Regain Under Dietary, Behavioural and Pharmacological Interventions in Healthy Obese SubjectsCompletedPhase 1GlaxoSmithKlineNCT01597609Written as sibutramineHow we know
- LOSS- Louisiana Obese Subjects StudyTerminatedPhase 4Pennington Biomedical Research CenterNCT00115063Written as sibutramine, orlistat, diethylpropionHow we know
- A Functional Magnetic Resonance Imaging (fMRI) Study in Overweight and Obese Men (0000-103)CompletedPhase 1Merck Sharp & Dohme LLCNCT00914212Written as Comparator: sibutramineHow we know
- A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese SubjectsCompletedPhase 2AstraZenecaNCT00402077Written as sibutramineHow we know
- Sibutramine to Reduce Weight Gain and Improve Smoking Cessation RatesCompletedNot applicableUniversity of TennesseeNCT00037752Written as SibutramineHow we know
- Sibutramine Versus Continuous Positive Airway Pressure (CPAP)in Obstructive Sleep Apnea (OSA) PatientsCompletedPhase 4Laval UniversityNCT00729963Written as SibutramineHow we know
- The Effect of Weight Loss on Anti-Müllerian Hormone Levels in Women With Polycystic Ovary Syndrome (PCOS)Status unknownPhase 4Aristotle University Of ThessalonikiNCT01475019Written as SibutramineHow we know
- A Weight Loss Study in Overweight Men and WomenTerminatedPhase 2Eli Lilly and CompanyNCT00993421Written as SibutramineHow we know
- Weight Loss in Response to Sibutramine (MERIDIA) is Influenced by the Inherited GenesCompletedPhase 4Mayo ClinicNCT00433641Written as sibutramineHow we know
- Assess the Additional Weight Loss Effect of Orlistat Used in Combination With SibutramineCompletedNot applicableGachon University Gil Medical CenterNCT01184560Written as SibutramineHow we know
- A Long Term Study of Sibutramine and the Role of Obesity Management in Relation to Cardiovascular Disease in Overweight and Obese PatientsCompletedPhase 3AbbottNCT00234832Written as Sibutramine hydrochlorideHow we know
- A Comparative Study of KES524 in Patients With Obesity DiseaseCompletedPhase 3Eisai LimitedNCT00165685Written as Sibutramine Hydrochloride MonohydrateHow we know
- Pharmacodynamic Effects of Sibutramine on Gastric Function in ObesityCompletedPhase 2Mayo ClinicNCT00330525Written as sibutramineHow we know
- A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects.CompletedPhase 4AbbottNCT00234988Written as sibutramine hydochloride monohydrateHow we know
- Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian PopulationCompletedPhase 3AbbottNCT00677391Written as SibutramineHow we know
- A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochloride) in Binge-Eating DisorderCompletedPhase 3AbbottNCT00402584Written as sibutramineHow we know
See all 23 studies that test sibutramine →
Given beside what is tested · 1 — sibutramine is usual care or a partner of the new treatment
As the comparator · 3 — what is tested is compared with sibutramine
- A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With OverweightWithdrawnPhase 3Eurofarma Laboratorios S.A.NCT05209984Written as SIB Group Sibus (Sibutramine) 15mgHow we know
- Sibutramine-metformin Combination Versus Sibutramine and Metformin Monotherapy in Obese PatientsStatus unknownPhase 3Laboratorios Silanes S.A. de C.V.NCT00941382Written as SibutramineHow we know
- A Study of Nasal PYY3-36 and Placebo for Weight Loss in Obese SubjectsCompletedPhase 2Nastech Pharmaceutical Company, Inc.NCT00537420Written as SibutramineHow we know
Codes
What other systems call sibutramine · ClinicalTrials.gg INT003410
- MeSH (NLM) C058254sibutramineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) WV5EC51866SIBUTRAMINEConfirmed FDA, NLM, Wikidata
- RxNorm 36514Confirmed FDA, Wikidata
- Wikidata Q424151(RS)-sibutramineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C75965SibutramineOne source FDA
- DrugBank DB01105One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C058254 | sibutramine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | WV5EC51866 | SIBUTRAMINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 36514 | — | Confirmed FDA, Wikidata |
| Wikidata | Q424151 | (RS)-sibutramine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C75965 | Sibutramine | One source FDA |
| DrugBank | DB01105 | — | One source Wikidata |
Also registered as sibutramine hydrochloride (UNII OGM0YHD1WF · RxNorm 221160).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.